Biological and clinical significance of monoclonal gammopathy

Published

Book Section

© Cambridge University Press 2008. Introduction: Monoclonal gammopathy of unknown significance (MGUS) affects up to 2% of persons aged 50 years or over, and about 3% of those older than 70 years. The aim of this chapter is to highlight some of the features of this disease process and its relationship to aging. It will focus on (1) epidemiology, (2) biology of MGUS and the role of various cytokines in the pathophysiology, (3) correlation of the biology of MGUS with aging, (4) diagnosis and follow-up of patients with MGUS, and (5) natural history and predictors of progression in patients with MGUS. Epidemiology: The monoclonal gammopathies are a group of disorders associated with proliferation of a single clone (monoclonal) of plasma cells. They are characterized by the secretion of an immunologically homogenous monoclonal protein (M-protein, M-component, M-spike, or paraprotein). Each M-protein consists of two heavy (H) polypeptide chains of the same class and subclass, and two light (L) chains of the same type. The heavy chains are IgG, IgM, IgA, IgD, and IgE, while the light-chain types are kappa (κ), and lambda (λ). In contrast, a polyclonal gammopathy is characterized by an increase in one or more heavy chains, and in both types of light chains, and is usually associated with an inflammatory or reactive process.

Full Text

Duke Authors

Cited Authors

  • Rao, AV; Cohen, HJ

Published Date

  • January 1, 2007

Book Title

  • Blood Disorders in the Elderly

Start / End Page

  • 138 - 154

International Standard Book Number 13 (ISBN-13)

  • 9780521875738

Digital Object Identifier (DOI)

  • 10.1017/CBO9780511545238.012

Citation Source

  • Scopus